Literature DB >> 2142979

Why do cancer cells have such a high glycolytic rate?

J M Argilés1, F J López-Soriano.   

Abstract

The high glycolytic rate of most tumor cells has puzzled biochemists for a long time. In the tumor, glucose is aerobically converted to lactate in the cytoplasm rather than being oxidized in the mitochondria. The molecular mechanisms underlying this phenomenon are still fragmentary. The present study supports the view that the origin of the glucose disposal by the tumor is multifactorial.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142979     DOI: 10.1016/0306-9877(90)90039-h

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  19 in total

1.  Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation.

Authors:  M Martin; B Beauvoit; P J Voisin; P Canioni; B Guérin; M Rigoulet
Journal:  J Bioenerg Biomembr       Date:  1998-12       Impact factor: 2.945

Review 2.  The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy.

Authors:  L C Costello; R B Franklin
Journal:  Oncology       Date:  2000-11       Impact factor: 2.935

Review 3.  Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.

Authors:  L C Costello; R B Franklin; Pei Feng
Journal:  Mitochondrion       Date:  2005-06       Impact factor: 4.160

4.  Microcalorimetric measurements carried out on isolated tumorous and nontumorous tissue samples from organs in the urogenital tract in comparison to histological and impulse-cytophotometric investigations.

Authors:  M Kallerhoff; M Karnebogen; D Singer; A Dettenbach; U Gralher; R H Ringert
Journal:  Urol Res       Date:  1996

5.  Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.

Authors:  Sílvia Busquets; Míriam Toledo; Sònia Sirisi; Marcel Orpí; Roberto Serpe; Joana Coutinho; Raquel Martínez; Josep M Argilés; Francisco J López-Soriano
Journal:  Exp Ther Med       Date:  2011-04-28       Impact factor: 2.447

Review 6.  Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield.

Authors:  K Brand
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

7.  Combination treatment based on metabolic effects of dinaline.

Authors:  H Schaider; U Haberkorn; E Petru; M R Berger
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 8.  DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy.

Authors:  Julie L Tubbs; Anthony E Pegg; John A Tainer
Journal:  DNA Repair (Amst)       Date:  2007-05-07

Review 9.  'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

10.  Differential cytotoxicity of buthionine sulfoximine to "normal" and transformed human lung fibroblast cells.

Authors:  X S Wan; D K St Clair
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.